Zoetis Inc. Class A boosts over 65 years of experience, having been founded in 1952 but just as a division of Pfizer, Inc. Through the years, the company engaged in numerous research and development projects, which led to the founding of Zoetis in 2012.
The global company produces medicine and vaccinations for livestock and pets, and it has set up its head office in New York, NY.
Primarily, Zoetis has its focus on supporting veterinarians and livestock producers. It delivers quality diagnostic products, vaccines, medicines, and a wide range of services. Every day, the company is working towards addressing the real-world challenges, constantly facing animal caregivers.
With a six-decade history, Zoetis has mastered its art building and sustaining beneficial business relationships with its partners and customers. The relationships have the full support of technical and veterinary specialists who offer exhaustive technical expertise and education on diseases. The company has a listing on the NYSE market and a global presence in over 100 countries.
Investing is speculative. When investing your capital is at risk. This site is not intended for use in jurisdictions in which the trading or investments described are prohibited and should only be used by such persons and in such ways as are legally permitted. Your investment may not qualify for investor protection in your country or state of residence, so please conduct your own due diligence. This website is free for you to use but we may receive commission from the companies we feature on this site. Click here for more information.